Lee (1980) presented survivial times in months from disagnosis for 71 patients with either acute myeloblastic leukemia (AML) or acute lymphoblastic lu\eukemia (ALL)
S. No
|
ATL
|
ALL
|
1
|
18
|
13
|
2
|
31
|
25
|
3
|
31
|
1
|
4
|
31
|
22
|
5
|
36
|
12
|
6
|
1
|
12
|
7
|
9
|
74
|
8
|
39
|
1
|
9
|
20
|
16
|
10
|
4
|
9
|
11
|
45
|
21
|
12
|
36
|
9
|
13
|
12
|
64
|
14
|
8
|
35
|
15
|
1
|
1
|
16
|
15
|
7
|
17
|
24
|
3
|
18
|
2
|
1
|
19
|
33
|
1
|
20
|
29
|
22
|
21
|
7
|
|
22
|
0
|
|
23
|
1
|
|
24
|
2
|
|
25
|
12
|
|
26
|
9
|
|
27
|
1
|
|
28
|
1
|
|
29
|
9
|
|
30
|
5
|
|
31
|
27
|
|
32
|
1
|
|
33
|
13
|
|
34
|
1
|
|
35
|
5
|
|
36
|
1
|
|
37
|
3
|
|
38
|
4
|
|
39
|
1
|
|
40
|
18
|
|
41
|
2
|
|
42
|
1
|
|
43
|
8
|
|
44
|
3
|
|
45
|
4
|
|
46
|
14
|
|
47
|
3
|
|
48
|
13
|
|
49
|
13
|
|
50
|
1
|
|
Compute the sample mean and median for both AML and ALL patients separately. Which evaluate do you believe is more appropriate to employ with these data? Describe